(LRN) Stride - Ratings and Ratios
Online Curriculum, Learning Platforms, Career Programs, Post-Secondary Training, Adult Upskilling
LRN EPS (Earnings per Share)
LRN Revenue
Description: LRN Stride November 06, 2025
Stride, Inc. (NYSE: LRN) delivers a suite of technology-driven curriculum, software platforms, and educational services to K-12 schools, public-charter districts, and adult learners in the United States and abroad. Its offerings span virtual and blended school operations, subject-specific learning tools (math, English, science, history), and post-secondary career pathways through the Galvanize, Tech Elevator, and MedCerts brands, plus staffing and talent-development services for employers.
Key operating metrics from the most recent FY 2023 filing show total revenue of roughly $1.2 billion, with a 9 % year-over-year increase driven primarily by growth in its post-secondary career-learning segment (up ~15 %). Enrollment across its K-12 virtual schools remained steady at about 250,000 students, while the adult-learner cohort expanded to over 100,000 active users, reflecting broader demand for up-skilling in tech and health-care fields.
The education-technology sector is currently benefitting from two macro drivers: (1) sustained federal and state funding for digital learning infrastructure, which historically adds 3–5 % to annual EdTech spend, and (2) a tight labor market that fuels employer-sponsored up-skilling programs-both of which support Stride’s diversified revenue streams. Conversely, regulatory scrutiny of virtual school funding and the competitive pressure from large platforms such as Pearson and Coursera remain material risks.
For a deeper quantitative view of Stride’s valuation metrics, you may find the ValueRay platform’s analyst dashboard useful.
LRN Stock Overview
| Market Cap in USD | 2,984m |
| Sub-Industry | Education Services |
| IPO / Inception | 2007-12-13 |
LRN Stock Ratings
| Growth Rating | 63.6% |
| Fundamental | 89.3% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -38.2% |
| Analyst Rating | 4.17 of 5 |
LRN Dividends
Currently no dividends paidLRN Growth Ratios
| Growth Correlation 3m | -69.7% |
| Growth Correlation 12m | 62.9% |
| Growth Correlation 5y | 95.8% |
| CAGR 5y | 27.48% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.45 |
| CAGR/Mean DD 3y (Pain Ratio) | 4.26 |
| Sharpe Ratio 12m | 0.99 |
| Alpha | -29.37 |
| Beta | 0.070 |
| Volatility | 38.70% |
| Current Volume | 1807k |
| Average Volume 20d | 961.7k |
| Stop Loss | 65.7 (-7%) |
| Signal | 0.03 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (315.9m TTM) > 0 and > 6% of Revenue (6% = 148.5m TTM) |
| FCFTA 0.16 (>2.0%) and ΔFCFTA 4.00pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 56.83% (prev 50.25%; Δ 6.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 379.0m > Net Income 315.9m (YES >=105%, WARN >=100%) |
| Net Debt (69.6m) to EBITDA (539.3m) ratio: 0.13 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (49.2m) change vs 12m ago 12.61% (target <= -2.0% for YES) |
| Gross Margin 39.20% (prev 38.21%; Δ 0.99pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 115.0% (prev 107.0%; Δ 7.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 37.72 (EBITDA TTM 539.3m / Interest Expense TTM 11.2m) >= 6 (WARN >= 3) |
Altman Z'' 7.75
| (A) 0.60 = (Total Current Assets 1.65b - Total Current Liabilities 243.6m) / Total Assets 2.33b |
| (B) 0.39 = Retained Earnings (Balance) 915.3m / Total Assets 2.33b |
| (C) 0.20 = EBIT TTM 423.5m / Avg Total Assets 2.15b |
| (D) 1.14 = Book Value of Equity 915.2m / Total Liabilities 805.7m |
| Total Rating: 7.75 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 89.26
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 12.66% = 5.0 |
| 3. FCF Margin 14.62% = 3.65 |
| 4. Debt/Equity 0.38 = 2.43 |
| 5. Debt/Ebitda 0.13 = 2.49 |
| 6. ROIC - WACC (= 13.90)% = 12.50 |
| 7. RoE 22.00% = 1.83 |
| 8. Rev. Trend 97.73% = 7.33 |
| 9. EPS Trend 40.48% = 2.02 |
What is the price of LRN shares?
Over the past week, the price has changed by +5.85%, over one month by -49.79%, over three months by -52.39% and over the past year by -29.00%.
Is Stride a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LRN is around 69.05 USD . This means that LRN is currently overvalued and has a potential downside of -2.22%.
Is LRN a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the LRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 122 | 72.8% |
| Analysts Target Price | 122 | 72.8% |
| ValueRay Target Price | 74.8 | 5.9% |
LRN Fundamental Data Overview November 02, 2025
P/E Trailing = 10.6147
P/E Forward = 17.331
P/S = 1.2057
P/B = 4.2824
P/EG = 0.8666
Beta = 0.07
Revenue TTM = 2.48b USD
EBIT TTM = 423.5m USD
EBITDA TTM = 539.3m USD
Long Term Debt = 416.3m USD (from longTermDebt, last fiscal year)
Short Term Debt = 65.8m USD (from shortTermDebt, last quarter)
Debt = 588.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 69.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.86b USD (2.98b + Debt 588.0m - CCE 715.1m)
Interest Coverage Ratio = 37.72 (Ebit TTM 423.5m / Interest Expense TTM 11.2m)
FCF Yield = 12.66% (FCF TTM 361.8m / Enterprise Value 2.86b)
FCF Margin = 14.62% (FCF TTM 361.8m / Revenue TTM 2.48b)
Net Margin = 12.76% (Net Income TTM 315.9m / Revenue TTM 2.48b)
Gross Margin = 39.20% ((Revenue TTM 2.48b - Cost of Revenue TTM 1.50b) / Revenue TTM)
Gross Margin QoQ = 39.00% (prev 36.55%)
Tobins Q-Ratio = 1.22 (Enterprise Value 2.86b / Total Assets 2.33b)
Interest Expense / Debt = 0.52% (Interest Expense 3.08m / Debt 588.0m)
Taxrate = 17.41% (14.4m / 82.8m)
NOPAT = 349.7m (EBIT 423.5m * (1 - 17.41%))
Current Ratio = 6.77 (Total Current Assets 1.65b / Total Current Liabilities 243.6m)
Debt / Equity = 0.38 (Debt 588.0m / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = 0.13 (Net Debt 69.6m / EBITDA 539.3m)
Debt / FCF = 0.19 (Net Debt 69.6m / FCF TTM 361.8m)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.54% (Net Income 315.9m / Total Assets 2.33b)
RoE = 22.00% (Net Income TTM 315.9m / Total Stockholder Equity 1.44b)
RoCE = 22.87% (EBIT 423.5m / Capital Employed (Equity 1.44b + L.T.Debt 416.3m))
RoIC = 19.21% (NOPAT 349.7m / Invested Capital 1.82b)
WACC = 5.31% (E(2.98b)/V(3.57b) * Re(6.27%) + D(588.0m)/V(3.57b) * Rd(0.52%) * (1-Tc(0.17)))
Discount Rate = 6.27% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 5.65%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈307.8m ; Y1≈379.7m ; Y5≈647.9m
Fair Price DCF = 251.3 (DCF Value 11.02b / Shares Outstanding 43.9m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 40.48 | EPS CAGR: 9.31% | SUE: 0.93 | # QB: 2
Revenue Correlation: 97.73 | Revenue CAGR: 11.66% | SUE: 0.36 | # QB: 0
Additional Sources for LRN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle